Best cost-effectiveness and worker productivity with initial triple DMARD therapy compared with methotrexate monotherapy in early rheumatoid arthritis: cost-utility analysis of the tREACH trial

Pascal de Jong, Mieke Hazes, Leander Buisman, PJ Barendregt, D van Zeben, PA van der Lubbe, AH Gerards, MH de Jager, PBJ de Sonnaville, BA Grillet, J.J. Luime, Angelique Weel

Research output: Contribution to journalArticleAcademicpeer-review

11 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)2138-2147
Number of pages10
Issue number12
Publication statusPublished - 2016

Cite this